Genetic Markers and Biomarkers in Patients With Intellectual Disabilities of Genetic Origin

Sponsor
Institut Jerome Lejeune
Study ID
NCT05767203
Status
Recruiting
Apply to this trial

Conditions

  • Down Syndrome
  • Intellectual Disability

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Accepted

Interventions

  • Biological samplings — OTHER
    Blood and/or skin samples

Study Details

Analyze genetic and biological markers in patients with Intellectual Deficiencies (ID) of genetic origin in order to better understand the mechanisms of modified genes, cellular mechanisms, pathways involved in different disorders , complications and pathologies associated with ID of genetic origin.

Key Dates

First listed
Mar 14, 2023
Start date
Sep 1, 2022
Status verified
Mar 2023
Primary completion
Sep 1, 2032
Completion
Dec 31, 2032

Study Design

Enrollment
2,000 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Patients with Down syndrome or other Intellectual deficiency of genetic origin
    Patients with Down syndrome or with other intellectual deficiency of genetic origin followed at the outpatients clinic of the Institut Jérôme Lejeune.

Primary Outcome Measure

Identification of biomarkers in blood [ Time Frame: 10 years ]

Central Contacts

Related Studies